These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16916863)

  • 1. Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling.
    Zhang X; Mehta RG; Lantvit DD; Coschigano KT; Kopchick JJ; Green JE; Hedayat S; Christov KT; Ray VH; Unterman TG; Swanson SM
    Carcinogenesis; 2007 Jan; 28(1):143-50. PubMed ID: 16916863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in the C3(1)/T antigen mouse.
    Wang Z; Prins GS; Coschigano KT; Kopchick JJ; Green JE; Ray VH; Hedayat S; Christov KT; Unterman TG; Swanson SM
    Endocrinology; 2005 Dec; 146(12):5188-96. PubMed ID: 16141391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis.
    Li M; Lewis B; Capuco AV; Laucirica R; Furth PA
    Oncogene; 2000 Feb; 19(8):1010-9. PubMed ID: 10713684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
    Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS
    Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.
    Yoshidome K; Shibata MA; Couldrey C; Korach KS; Green JE
    Cancer Res; 2000 Dec; 60(24):6901-10. PubMed ID: 11156389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
    Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
    Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors.
    Wu Y; Cui K; Miyoshi K; Hennighausen L; Green JE; Setser J; LeRoith D; Yakar S
    Cancer Res; 2003 Aug; 63(15):4384-8. PubMed ID: 12907608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice.
    Zhang H; Kuang SQ; Liao L; Zhou S; Xu J
    Cancer Res; 2004 Oct; 64(19):7169-77. PubMed ID: 15466215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
    Lincoln DT; Singal PK; Al-Banaw A
    Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation.
    Yang XF; Beamer WG; Huynh H; Pollak M
    Cancer Res; 1996 Apr; 56(7):1509-11. PubMed ID: 8603394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol promotes mammary tumor development via the estrogen pathway in estrogen receptor alpha-negative HER2/neu mice.
    Wong AW; Dunlap SM; Holcomb VB; Nunez NP
    Alcohol Clin Exp Res; 2012 Apr; 36(4):577-87. PubMed ID: 21981381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
    Wu K; Kim HT; Rodriquez JL; Hilsenbeck SG; Mohsin SK; Xu XC; Lamph WW; Kuhn JG; Green JE; Brown PH
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):467-74. PubMed ID: 12010861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haploid loss of Ki-ras delays mammary tumor progression in C3 (1)/SV40 Tag transgenic mice.
    Liu ML; Shibata MA; Von Lintig FC; Wang W; Cassenaer S; Boss GR; Green JE
    Oncogene; 2001 Apr; 20(16):2044-9. PubMed ID: 11360188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SV40 T-antigen induces breast cancer formation with a high efficiency in lactating and virgin WAP-SV-T transgenic animals but with a low efficiency in ovariectomized animals.
    Santarelli R; Tzeng YJ; Zimmermann C; Guhl E; Graessmann A
    Oncogene; 1996 Feb; 12(3):495-505. PubMed ID: 8637705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammary Tumor Growth and Proliferation Are Dependent on Growth Hormone in Female SV40 C3(1) T-Antigen Mice.
    Unterberger CJ; McGregor SM; Kopchick JJ; Swanson SM; Marker PC
    Endocrinology; 2022 Dec; 164(2):. PubMed ID: 36269749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen inhibition of estrogen receptor-alpha-negative mouse mammary tumorigenesis.
    Medina D; Kittrell FS; Hill J; Shepard A; Thordarson G; Brown P
    Cancer Res; 2005 Apr; 65(8):3493-6. PubMed ID: 15833886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chaperoning of estrogen receptor and induction of mammary gland proliferation by neuronal protein synuclein gamma.
    Liu YE; Pu W; Jiang Y; Shi D; Dackour R; Shi YE
    Oncogene; 2007 Mar; 26(14):2115-25. PubMed ID: 17016445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of growth hormone and insulin-like growth factor I on muscle in mouse models of human growth disorders.
    Clark RP; Schuenke M; Keeton SM; Staron RS; Kopchick JJ
    Horm Res; 2006; 66 Suppl 1():26-34. PubMed ID: 17259718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of circulating growth hormone on muscle IGF-I protein concentration in female mice with growth hormone receptor gene disruption.
    Kraemer WJ; Vingren JL; Schuenke MD; Kopchick JJ; Volek JS; Fragala MS; Häkkinen K; Jen-Ho ; Thomas GA; Staron RS
    Growth Horm IGF Res; 2009 Jun; 19(3):242-4. PubMed ID: 19083250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone (GH) receptor knockout mice reveal actions of GH in lung development.
    Beyea JA; Sawicki G; Olson DM; List E; Kopchick JJ; Harvey S
    Proteomics; 2006 Jan; 6(1):341-8. PubMed ID: 16287172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.